Wangda Zhou

419 total citations
18 papers, 329 citations indexed

About

Wangda Zhou is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Wangda Zhou has authored 18 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pharmacology. Recurrent topics in Wangda Zhou's work include Pharmacogenetics and Drug Metabolism (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Pharmaceutical studies and practices (3 papers). Wangda Zhou is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Pharmaceutical studies and practices (3 papers). Wangda Zhou collaborates with scholars based in United States, United Kingdom and Netherlands. Wangda Zhou's co-authors include Amy C. Anderson, Dennis L. Wright, Diansong Zhou, Nidal Al‐Huniti, Hongmei Xu, Mohamed Ammar, E. Zachary Oblak, Trevor N. Johnson, Jianguo Li and Khanh Bui and has published in prestigious journals such as Journal of Medicinal Chemistry, Clinical Pharmacology & Therapeutics and Drug Metabolism and Disposition.

In The Last Decade

Wangda Zhou

16 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wangda Zhou United States 9 103 78 70 68 66 18 329
Kale Mohana Raghava Srivalli India 6 88 0.9× 36 0.5× 25 0.4× 27 0.4× 106 1.6× 7 361
Helen Gu United States 12 112 1.1× 38 0.5× 110 1.6× 109 1.6× 117 1.8× 19 507
Michael P. Kozar United States 13 127 1.2× 131 1.7× 27 0.4× 72 1.1× 92 1.4× 26 463
Erin Hugger United States 8 130 1.3× 39 0.5× 39 0.6× 52 0.8× 262 4.0× 8 487
Rahul Vats India 10 124 1.2× 40 0.5× 22 0.3× 34 0.5× 34 0.5× 20 468
Karishma Patel Australia 10 250 2.4× 75 1.0× 42 0.6× 35 0.5× 143 2.2× 24 512
Ricardo Nalda‐Molina Spain 11 102 1.0× 16 0.2× 105 1.5× 30 0.4× 126 1.9× 25 437
Sibo Jiang United States 13 297 2.9× 154 2.0× 31 0.4× 42 0.6× 45 0.7× 25 609
Alexis Moréno France 13 111 1.1× 105 1.3× 30 0.4× 27 0.4× 186 2.8× 22 336
Robert T. Koda United States 15 102 1.0× 32 0.4× 63 0.9× 39 0.6× 37 0.6× 35 520

Countries citing papers authored by Wangda Zhou

Since Specialization
Citations

This map shows the geographic impact of Wangda Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wangda Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wangda Zhou more than expected).

Fields of papers citing papers by Wangda Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wangda Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wangda Zhou. The network helps show where Wangda Zhou may publish in the future.

Co-authorship network of co-authors of Wangda Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Wangda Zhou. A scholar is included among the top collaborators of Wangda Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wangda Zhou. Wangda Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhou, Wangda, Gregory E. Alexander, Matthew L. Zierhut, et al.. (2025). Quantitative Model‐Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation. Clinical Pharmacology & Therapeutics. 119(1). 139–146.
2.
Lee, Jong Bong, Wangda Zhou, Zhenhua Xu, Joseph A. Hedrick, & Jocelyn H. Leu. (2023). Population Pharmacokinetics and Exposure‐Response Modeling Analyses of Golimumab in Children and Young Adults With Recently Diagnosed Type 1 Diabetes. The Journal of Clinical Pharmacology. 63(6). 721–731.
3.
Willmann, Stefan, Ibrahim Ince, Maurice J. Ahsman, et al.. (2022). Model‐informed bridging of rivaroxaban doses for thromboprophylaxis in pediatric patients aged 9 years and older with congenital heart disease. CPT Pharmacometrics & Systems Pharmacology. 11(8). 1111–1121. 6 indexed citations
4.
Zhou, Wangda, et al.. (2022). Population‐based cellular kinetic characterization of ciltacabtagene autoleucel in subjects with relapsed or refractory multiple myeloma. Clinical and Translational Science. 15(12). 3000–3011. 7 indexed citations
5.
Zhu, Peijuan, Stefan Willmann, Wangda Zhou, et al.. (2021). Dosing Regimen Prediction and Confirmation With Rivaroxaban for Thromboprophylaxis in Children After the Fontan Procedure: Insights From the Phase III UNIVERSE Study. The Journal of Clinical Pharmacology. 62(2). 220–231. 8 indexed citations
6.
Wang, Lujing, Yang Chen, Wangda Zhou, Xin Miao, & Honghui Zhou. (2021). Utilization of physiologically‐based pharmacokinetic model to assess disease‐mediated therapeutic protein‐disease‐drug interaction in immune‐mediated inflammatory diseases. Clinical and Translational Science. 15(2). 464–476. 11 indexed citations
7.
Zhou, Wangda, Chuanpu Hu, Yaowei Zhu, et al.. (2020). Extrapolating Pharmacodynamic Effects From Adults to Pediatrics: A Case Study of Ustekinumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis. Clinical Pharmacology & Therapeutics. 109(1). 131–139. 3 indexed citations
8.
Zhou, Wangda, Dolly A. Parasrampuria, Susumu Nakahara, et al.. (2018). Population Pharmacokinetic Analysis of Decitabine in Pediatric Patients With Acute Myeloid Leukemia. The Journal of Clinical Pharmacology. 59(5). 668–676. 3 indexed citations
9.
Chen, Yingxue, Diansong Zhou, Weifeng Tang, et al.. (2017). Physiologically Based Pharmacokinetic Modeling to Evaluate the Systemic Exposure of Gefitinib in CYP2D6 Ultrarapid Metabolizers and Extensive Metabolizers. The Journal of Clinical Pharmacology. 58(4). 485–493. 19 indexed citations
10.
Zhou, Wangda, Sibylle Neuhoff, Iain Gardner, et al.. (2017). Development of a physiologically based pharmacokinetic model to predict the effects of flavin‐containing monooxygenase 3 (FMO3) polymorphisms on itopride exposure. Biopharmaceutics & Drug Disposition. 38(6). 389–393. 6 indexed citations
11.
Zhou, Wangda, Bruce K. Birmingham, Hongmei Xu, et al.. (2017). Population Pharmacokinetic Analysis of Zolmitriptan and Its Metabolite in Adults and Adolescents to Support Dose Selection in Children With Migraine. The Journal of Clinical Pharmacology. 57(10). 1258–1267. 1 indexed citations
12.
Zhou, Wangda, Trevor N. Johnson, Khanh Bui, et al.. (2017). Predictive Performance of Physiologically Based Pharmacokinetic (PBPK) Modeling of Drugs Extensively Metabolized by Major Cytochrome P450s in Children. Clinical Pharmacology & Therapeutics. 104(1). 188–200. 63 indexed citations
13.
Xu, Hongmei, Wangda Zhou, Diansong Zhou, Jianguo Li, & Nidal Al‐Huniti. (2016). Evaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis. The Journal of Clinical Pharmacology. 57(3). 336–344. 24 indexed citations
14.
Paulsen, Janet L., Kishore Viswanathan, Santosh Keshipeddy, et al.. (2014). Propargyl-Linked Antifolates are Dual Inhibitors of Candida albicans and Candida glabrata. Journal of Medicinal Chemistry. 57(6). 2643–2656. 36 indexed citations
15.
Zhou, Wangda, et al.. (2013). Antifolates as effective antimicrobial agents: new generations of trimethoprim analogs. MedChemComm. 4(6). 908–908. 21 indexed citations
16.
Oblak, E. Zachary, et al.. (2013). Tropolones As Lead-Like Natural Products: The Development of Potent and Selective Histone Deacetylase Inhibitors. ACS Medicinal Chemistry Letters. 4(8). 757–761. 86 indexed citations
17.
Zhou, Wangda, Kishore Viswanathan, Dennis W. Hill, Amy C. Anderson, & Dennis L. Wright. (2012). Acetylenic Linkers in Lead Compounds: A Study of the Stability of the Propargyl-Linked Antifolates. Drug Metabolism and Disposition. 40(10). 2002–2008. 10 indexed citations
18.
Wei, Lixia, Shunyi Li, Jianhua Yang, et al.. (2010). Protein-Based MRI Contrast Agents for Molecular Imaging of Prostate Cancer. Molecular Imaging and Biology. 13(3). 416–423. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kale Mohana Raghava Srivalli Breakdown of academic impact, for papers by Helen Gu Breakdown of academic impact, for papers by Michael P. Kozar Breakdown of academic impact, for papers by Erin Hugger Breakdown of academic impact, for papers by Rahul Vats Breakdown of academic impact, for papers by Karishma Patel Breakdown of academic impact, for papers by Ricardo Nalda‐Molina Breakdown of academic impact, for papers by Sibo Jiang Breakdown of academic impact, for papers by Alexis Moréno Breakdown of academic impact, for papers by Robert T. Koda
Rankless by CCL
2026